Beam Therapeutics Inc (BEAM) — Free Cash Flow Generation Index
Beam Therapeutics Inc (BEAM) has a Free Cash Flow Generation Index of 0.97x as of December 2023. Free cash flow of $131.48 Million represents 1% of operating cash flow ($135.07 Million). See BEAM working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Beam Therapeutics Inc Free Cash Flow Generation Index (2022–2022)
Historical FCF Generation Index trend for Beam Therapeutics Inc across 1 annual periods. Explore BEAM operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Beam Therapeutics Inc (2022–2022)
Year-by-year Free Cash Flow Generation Index for Beam Therapeutics Inc. For the full company profile including market capitalisation, see market cap of Beam Therapeutics Inc.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | -1.17x | $-26.42 Million | $22.53 Million | $48.95 Million | — |